These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A. Antimicrob Agents Chemother; 2007 Dec; 51(12):4329-35. PubMed ID: 17938181 [Abstract] [Full Text] [Related]
52. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China. Zeng ZR, Wang WP, Huang M, Shi LN, Wang Y, Shao HF. Diagn Microbiol Infect Dis; 2014 Mar; 78(3):268-70. PubMed ID: 24359931 [Abstract] [Full Text] [Related]
56. Changes in the resistance and epidemiological characteristics of Pseudomonas aeruginosa during a ten-year period. Feng W, Huang Q, Wang Y, Yuan Q, Li X, Xia P, Sun F. J Microbiol Immunol Infect; 2021 Apr; 54(2):261-266. PubMed ID: 31628088 [Abstract] [Full Text] [Related]
59. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. Pournaras S, Maniati M, Spanakis N, Ikonomidis A, Tassios PT, Tsakris A, Legakis NJ, Maniatis AN. J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825 [Abstract] [Full Text] [Related]